Achillion Pharma (ACHN) Raises $50M from Recent Share Sale

Between December 22, 2014 and December 31, 2014, Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) (the “Company”) sold shares of its common stock pursuant to the Sales Agreement, dated November 8, 2012, between the Company and Cantor Fitzgerald & Co., resulting in aggregate gross proceeds to the Company of $50 million. After giving effect to these sales, the Company estimates that its cash will be sufficient to meet its projected operating requirements into the fourth quarter of 2016.

You May Also Be Interested In

• Pyxis Oncology (PYXS) files for 39.2M share offering by selling stockholders
• Simmons Bank chief data officer Lisa Hunter to retire
• Genworth Financial CEO returns from leave of absence in September